Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ren Fail ; 37(2): 280-4, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25540869

ABSTRACT

BACKGROUND: In this study, we investigated the protective effect of thymol as a natural compound against cisplatin-induced nephrotoxicity by quantitative renal 99mTc-DMSA uptake and compared its effect with histopathology in mice. MATERIALS AND METHODS: Mice were divided into six groups as control, cisplatin (7.5 mg/kg, intraperitoneally), thymol+cisplatin (thymol; 50 and 150 mg/kg+cisplatin; 7.5 mg/kg) and thymol (50 and 150 mg/kg). Thymol was orally administrated for two days before cisplatin injection and continued for 4 days. (99m)Tc-DMSA was injected through the tail of mice after the drug administration. The percentage of the injected dose per gram of kidney tissue (%ID/g) was calculated. In other experiment, kidneys of treated mice were assessed for histopathology. RESULTS: 99mTc-DMSA uptake per gram tissue of the kidneys as %ID/g was 85.27±21.81, 45.55±5.50, 65.02±32.21 and 88.46±20.46 in the control, cisplatin, thymol (50 mg/kg)+cisplatin and thymol (150 mg/kg)+cisplatin. Thymol administration with cisplatin resulted in a significant increase in the level of %ID/g. Histopathological examinations showed a protective effect of thymol against cisplatin nephrotoxicity in mice. CONCLUSION: The results showed that thymol significantly attenuates the cisplatin-induced nephrotoxicity in mice, and 99mTc-DMSA uptake in kidney is a suitable method for assessment of nephrotoxicity in mice.


Subject(s)
Antineoplastic Agents, Alkylating/adverse effects , Cisplatin , Kidney Diseases , Kidney , Technetium Tc 99m Dimercaptosuccinic Acid/pharmacology , Thymol/pharmacology , Animals , Antineoplastic Agents, Alkylating/administration & dosage , Antioxidants/pharmacology , Cisplatin/pharmacokinetics , Cisplatin/toxicity , Creatinine/analysis , Dose-Response Relationship, Drug , Kidney/diagnostic imaging , Kidney/physiopathology , Kidney Diseases/chemically induced , Kidney Diseases/diagnosis , Kidney Diseases/physiopathology , Male , Mice , Protective Agents/pharmacology , Radionuclide Imaging , Radiopharmaceuticals/pharmacology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...